Start
Features
Free trial / FAQ

Researchers
Physicians
Pharmacists
Ecotrophologists
Product Managers
in Health Industries

Loading…

Medical Research Finder

Legal Notice
Privacy
Terms of Use

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

meRfi® AI Chat

Galactooligosaccharides (GOS) & Type 2 Diabetes (T2D)

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

(Login)

Navigation

UMIN000012234 - Galactooligosaccharides (GOS) & Type 2 Diabetes (T2D)

This randomized, placebo-controlled clinical trial revealed that Galactooligosaccharides (GOS) can help improve dysbiosis in patients with diabetes. Continuous intake of GOS might be a promising approach for managing type 2 diabetes (1).

References

(1) Gonai et al. 2017 Benef Microbes 8: 705-716

…

References (Sources)

Galacto-oligosaccharides ameliorate dysbiotic Biﬁdobacteriaceae decline in Japanese patients with type 2 diabetes
Gonai et al. 2017 Benef Microbes 8: 705-716

AI Chat

7/1/2026

Chat with our artificial intelligence:

Start chat!